
Overview
Dr. Jolie L. Chang is an otolaryngologist who specializes in surgery to treat obstructive sleep apnea. She serves as chief of the UCSF Division of Sleep Surgery. She has expertise in sleep endoscopy (a technique for assessing the airway during sleep) and upper airway surgery, snoring surgery, palate surgery, tongue base surgery and hypoglossal nerve stimulation implant surgery (implanting a device that controls tongue movement in sleep). She also specializes in minimally invasive surgery for noncancerous salivary gland disorders (such as salivary stones) with sialendoscopy (a method of examining the salivary gland openings and removing obstructions using a very small endoscope). She treats salivary blockage from stones and salivary issues related to treatment with radioactive iodine. She is also an expert in ultrasound of the head and neck and ear, nose and throat disorders. Chang's research interests include decision making in health care and improvements for sleep apnea therapy and sialendoscopy. She has written on topics related to hearing loss, salivary obstruction symptoms and treatment, otolaryngology resident perspectives, and smell and taste changes related to COVID-19. She has also authored book chapters on sleep apnea therapies, salivary disorders and imaging for salivary glands. She serves as the director of resident research for otolaryngology – head and neck surgery. Chang graduated from the Massachusetts Institute of Technology with a bachelor's degree and a master of engineering degree in electrical engineering and computer science. She earned her medical degree and completed her residency in otolaryngology – head and neck surgery at UCSF. She is a fellow of the American College of Surgeons.
Dr. Chang is highly rated in 13 conditions, according to our data. Her top areas of expertise are Sialadenitis, Salivary Duct Stones, Obstructive Sleep Apnea, Endoscopy, and Stapedectomy.
Her clinical research consists of co-authoring 88 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2380 Sutter St., Third Floor, San Francisco, CA 94115
2380 Sutter St., Third Floor, San Francisco, CA 94115
2380 Sutter St., San Francisco, CA 94115
520 Illinois St., San Francisco, CA 94158
3100 San Pablo Ave., Berkeley, CA 94702
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Head And Neck Surgery Cancer Program
Dr. Patrick Ha is chief of the UCSF Division of Head and Neck Surgical Oncology. His expertise in patient care covers the full scope of head and neck surgery, with a focus on thyroid and parathyroid surgery as well as endoscopic approaches to throat cancer surgery. Ha's research is currently focused on molecular changes that occur in adenoid cystic carcinoma of the salivary gland. Ha received an undergraduate degree in biology from Harvard University, graduating magna cum laude. He obtained his medical degree from Johns Hopkins School of Medicine, graduating with membership in the Alpha Omega Alpha Honor Medical Society. He then completed his residency training and a postdoctoral fellowship at the otolaryngology department of Johns Hopkins, along with advanced fellowship training in head and neck oncologic surgery. Ha serves on the editorial board of several medical journals, including Oral Oncology. He is the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in Head and Neck Cancer. Dr. Ha is highly rated in 20 conditions, according to our data. His top areas of expertise are Adenoid Cystic Carcinoma, Salivary Gland Tumors, Tongue Cancer, Gastrostomy, and Laryngectomy.
Head And Neck Medical Oncology Program
Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is highly rated in 25 conditions, according to our data. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.
Head And Neck Surgery Cancer Program
Dr. Ivan H. El-Sayed is a head and neck cancer surgeon. He specializes in treating benign and malignant lesions of the salivary glands, paranasal sinuses and skull base. El-Sayed's research interests include examining the value of sentinel node biopsy (a procedure to check whether cancer has spread) for head and neck cancer. He also is investigating potential uses of lasers and nanoparticles for diagnosing and treating cancer. El-Sayed earned his medical degree and completed a residency in otolaryngology at Boston University School of Medicine. He completed a fellowship in head and neck oncology at UCSF. Dr. El is highly rated in 21 conditions, according to our data. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Turbinectomy.
Frequently Asked Questions about Dr. Jolie L. Chang
How do I make an appointment with Dr. Jolie L. Chang?
You can book an appointment with Dr. Jolie L. Chang by calling their office at 415-353-2757. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jolie L. Chang a top-rated expert for Sialadenitis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jolie L. Chang is classified as an Elite expert for Sialadenitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jolie L. Chang specialize in?
While Dr. Jolie L. Chang is a Otolaryngology, they have specific expertise in Sialadenitis, Salivary Duct Stones, and Obstructive Sleep Apnea. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Otolaryngology.
Does Dr. Jolie L. Chang participate in research or clinical trials?
Yes. Dr. Jolie L. Chang has published 88 articles and abstracts on conditions like Sialadenitis. You can view a list of Dr. Jolie L. Chang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jolie L. Chang accept my insurance?
Dr. Jolie L. Chang accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-353-2757 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Salivary Duct StonesDr. Chang isElite. Learn about Salivary Duct Stones.
- SialadenitisDr. Chang isElite. Learn about Sialadenitis.
- Distinguished
- Obstructive Sleep ApneaDr. Chang isDistinguished. Learn about Obstructive Sleep Apnea.
- Advanced
- Dry MouthDr. Chang isAdvanced. Learn about Dry Mouth.
- Familial DeafnessDr. Chang isAdvanced. Learn about Familial Deafness.
- Fibrous DysplasiaDr. Chang isAdvanced. Learn about Fibrous Dysplasia.
- Hearing LossDr. Chang isAdvanced. Learn about Hearing Loss.
- Infant Hearing LossDr. Chang isAdvanced. Learn about Infant Hearing Loss.
- Low Nasal BridgeDr. Chang isAdvanced. Learn about Low Nasal Bridge.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- AnosmiaDr. Chang isExperienced. Learn about Anosmia.
- Aseptic and Alopecic Nodules of Scalp (AANS)
- Autonomic NeuropathyDr. Chang isExperienced. Learn about Autonomic Neuropathy.
- CholesteatomaDr. Chang isExperienced. Learn about Cholesteatoma.
- Deafness Hypogonadism SyndromeDr. Chang isExperienced. Learn about Deafness Hypogonadism Syndrome.



